skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 705,198  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Material Type:
Article
Add to My Research

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Nature (London), 2018-09, Vol.561 (7724), p.479-484 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Sep 27, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-018-0531-2 ;PMID: 30258136

Full text available

2
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Material Type:
Article
Add to My Research

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Nature (London), 2015-06, Vol.522 (7557), p.487-491 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jun 25, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14411 ;PMID: 25855300 ;CODEN: NATUAS

Full text available

3
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Material Type:
Article
Add to My Research

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Nature (London), 2020-08, Vol.584 (7821), p.450-456 [Peer Reviewed Journal]

Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2571-7 ;PMID: 32698192

Full text available

4
Combination anti-HIV antibodies provide sustained virological suppression
Material Type:
Article
Add to My Research

Combination anti-HIV antibodies provide sustained virological suppression

Nature (London), 2022-06, Vol.606 (7913), p.375-381 [Peer Reviewed Journal]

2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. ;Copyright Nature Publishing Group Jun 9, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04797-9 ;PMID: 35650437

Full text available

5
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
Material Type:
Article
Add to My Research

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

Nature (London), 2014-10, Vol.514 (7524), p.642-645 [Peer Reviewed Journal]

COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 30, 2014 ;2014 Macmillan Publishers Limited. All rights reserved 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature13612 ;PMID: 25119033 ;CODEN: NATUAS

Full text available

6
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Material Type:
Article
Add to My Research

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

Nature (London), 2016-05, Vol.533 (7601), p.105-109 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group May 5, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature17677 ;PMID: 27120156 ;CODEN: NATUAS

Full text available

7
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Material Type:
Article
Add to My Research

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Nature structural & molecular biology, 2020-09, Vol.27 (9), p.846-854 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. corrected publication 2021. ;ISSN: 1545-9993 ;EISSN: 1545-9985 ;DOI: 10.1038/s41594-020-0469-6 ;PMID: 32661423

Full text available

8
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Material Type:
Article
Add to My Research

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Science, 2021-02, Vol.371 (6530), p.691 [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1095-9203 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abe6230

Digital Resources/Online E-Resources

9
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
Material Type:
Article
Add to My Research

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Science, 2021-02, Vol.371 (6531) [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf4830

Digital Resources/Online E-Resources

10
Evolution of antibody immunity to SARS-CoV-2
Material Type:
Article
Add to My Research

Evolution of antibody immunity to SARS-CoV-2

Nature (London), 2021-03, Vol.591 (7851), p.639-644 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Mar 25, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03207-w ;PMID: 33461210

Full text available

11
Broad dengue neutralization in mosquitoes expressing an engineered antibody
Material Type:
Article
Add to My Research

Broad dengue neutralization in mosquitoes expressing an engineered antibody

PLoS pathogens, 2020-01, Vol.16 (1), p.e1008103 [Peer Reviewed Journal]

2020 Buchman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2020 Buchman et al 2020 Buchman et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1008103 ;PMID: 31945137

Full text available

12
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Material Type:
Article
Add to My Research

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Cell, 2020-11, Vol.183 (4), p.1024-1042.e21 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.09.037 ;PMID: 32991844

Digital Resources/Online E-Resources

13
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Material Type:
Article
Add to My Research

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Science, 2020-06, Vol.368 (6496) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc2241

Digital Resources/Online E-Resources

14
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
Material Type:
Article
Add to My Research

Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection

Cell host & microbe, 2019-01, Vol.25 (1), p.39-48.e5 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.12.004 ;PMID: 30629917

Full text available

15
An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants
Material Type:
Article
Add to My Research

An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants

Structure (London), 2021-06, Vol.29 (6), p.606-621.e5 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;ISSN: 0969-2126 ;EISSN: 1878-4186 ;DOI: 10.1016/j.str.2021.01.005 ;PMID: 33539768

Full text available

16
Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques
Material Type:
Article
Add to My Research

Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques

PloS one, 2019-02, Vol.14 (2), p.e0212649 [Peer Reviewed Journal]

COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Rosenberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Rosenberg et al 2019 Rosenberg et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0212649 ;PMID: 30785963

Full text available

17
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
Material Type:
Article
Add to My Research

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies

Frontiers in immunology, 2020-08, Vol.11, p.1951 [Peer Reviewed Journal]

Copyright © 2020 Vaisman-Mentesh, Gutierrez-Gonzalez, DeKosky and Wine. ;COPYRIGHT 2020 Frontiers Research Foundation ;Copyright © 2020 Vaisman-Mentesh, Gutierrez-Gonzalez, DeKosky and Wine. 2020 Vaisman-Mentesh, Gutierrez-Gonzalez, DeKosky and Wine ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2020.01951 ;PMID: 33013848

Full text available

18
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Material Type:
Article
Add to My Research

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Nature (London), 2021-08, Vol.596 (7870), p.103-108 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Aug 5, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03720-y ;PMID: 34153975

Full text available

19
The role of IgG Fc receptors in antibody-dependent enhancement
Material Type:
Article
Add to My Research

The role of IgG Fc receptors in antibody-dependent enhancement

Nature reviews. Immunology, 2020-10, Vol.20 (10), p.633-643 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00410-0 ;PMID: 32782358

Full text available

20
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Material Type:
Article
Add to My Research

Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques

Nature (London), 2019-06, Vol.570 (7762), p.468-473 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jun 27, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1250-z ;PMID: 31142836

Full text available

Results 1 - 20 of 705,198  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (633,782)

Refine My Results

Creation Date 

From To
  1. Before 1961  (4,246)
  2. 1961 To 1976  (40,341)
  3. 1977 To 1992  (135,602)
  4. 1993 To 2009  (212,704)
  5. After 2009  (312,539)
  6. More options open sub menu

Subject 

  1. Science & Technology  (538,205)
  2. Life Sciences & Biomedicine  (493,174)
  3. Humans  (355,216)
  4. Animals  (270,948)
  5. Antibodies  (192,590)
  6. Female  (177,659)
  7. Biological And Medical Sciences  (173,943)
  8. Male  (150,641)
  9. Immunology  (135,819)
  10. Mice  (124,003)
  11. Fundamental And Applied Biological Sciences. Psychology  (96,690)
  12. Adult  (89,555)
  13. Medical Sciences  (89,503)
  14. Proteins  (80,778)
  15. Monoclonal Antibodies  (78,991)
  16. Middle Aged  (76,861)
  17. Microbiology  (70,630)
  18. Infectious Diseases  (64,221)
  19. Fluorescent Antibody Technique  (62,714)
  20. Antigens  (59,287)
  21. More options open sub menu

Language 

  1. English  (693,045)
  2. Japanese  (90,586)
  3. Portuguese  (3,913)
  4. French  (3,458)
  5. German  (3,014)
  6. Spanish  (2,728)
  7. Russian  (1,258)
  8. Chinese  (623)
  9. Korean  (521)
  10. Norwegian  (384)
  11. Polish  (382)
  12. Italian  (373)
  13. Turkish  (293)
  14. Persian  (121)
  15. Swedish  (103)
  16. Czech  (100)
  17. Croatian  (69)
  18. Serbian  (47)
  19. Slovak  (36)
  20. Dutch  (29)
  21. More options open sub menu

Searching Remote Databases, Please Wait